Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Plos Biology|July 18, 2008
Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantationDale Christiansen, Julie Milland, Effie Mouhtouris, et al.Frontiers in Immunology|April 5, 2021
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal StudyAna Copaescu, Fiona James, Effie Mouhtouris, et al.Immunology and Cell Biology|February 2, 2011
Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cellsDale Christiansen, Hilary A Vaughan, Julie Milland, et al.Transplantation Direct|January 2, 2023
Australian Donation and Transplantation Biobank: A Research Biobank Integrated Within a Deceased Organ and Tissue Donation ProgramVarun J Sharma, Graham Starkey, Rohit D'Costa, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Blister fluid as a cellular input for <i>ex vivo</i> diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesisAndrew Awad, Effie Mouhtouris, Catriona Vi Nguyen-Robertson, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2021
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug ReactionsAna Copaescu, Effie Mouhtouris, Sara Vogrin, et al.The Journal of Investigative Dermatology|September 4, 2025
Analysis of skin immune cells in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)Allison Clatch, Jason A Trubiano, , et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 14, 2025
The role of skin testing, drug challenge and IFN-γ ELISpot in delayed hypersensitivity to iodinated contrast mediaAna Maria Copaescu, Kyra Y L Chua, Effie Mouhtouris, et al.Open Forum Infectious Diseases|September 13, 2021
Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral ReplicationClaire L Gordon, Olivia C Smibert, Natasha E Holmes, et al.BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.Pageof 3